Andrew Wang, MD, PhD

Dr. Andrew Wang earned his AB from Harvard and his MD/PhD from UT Southwestern, with additional training at the University of Paris. His doctoral work uncovered a role for the CXCR4/SDF-1 axis in end-organ targeting in lupus. After completing internal medicine residency and rheumatology fellowship at Yale, he pursued postdoctoral training in Dr. Ruslan Medzhitov’s lab, where he studied how inflammation and metabolism are coordinated across the organism—work that has shaped our understanding of inflammatory disease. Dr. Wang’s lab investigates how environmental factors influence inflammatory disease trajectories, using approaches spanning physiology, metabolism, immunology, and neurobiology. Key research areas include inflammatory physiology, energy allocation in host defense, placebo/nocebo mechanisms, and the interplay between cell death and inflammation. Clinically, he cares for patients with inflammatory and rheumatologic diseases, often of unclear etiology.